Prescribing information:
Long-term prophylaxis of supraventricular and ventricular arrhythmias (specialist use only)
- By mouth, for ventricular arrhythmias, initially 100 mg twice daily. Maximum dose 400 mg daily in exceptional cases.
- By mouth, for supraventricular arrhythmias, 50 mg twice daily, increased if required to a maximum of 300 mg daily
Flecainide can be used for the treatment of SVT and VT, but its principal use is for the termination of acute atrial fibrillation.
- It can be used in patients with Wolff-Parkinson-White syndrome.
- See adenosine for more information on treatment of SVT.
Advertisements
